Wang et al. [37] developed superparamagnetic iron oxide NPs (SPIO NPs) modified with an antibody vs Epidermal Growth Factor Receptor (EGFR) to perform active targeting in lung cancer cells (H460). The gene discussed is EGFR; the disease is lung cancer.